New Zealand shares slipped into the red Thursday as stocks tracked losses from Wall Street and investors weighed the latest batch of earnings reports.

The S&P/NZX 50 Index lost 1.2%, or 159.36 points, to close at 13,053.56 but hit a new 52-week high during the session.

The index pared its gains to 2.3% over the past trading days. Electronic technology shares led the decline as the segment lost 6%. This was followed by health services, which fell 3.4%.

Asian peers were mixed, with Hong Kong's Hang Seng and Shanghai's SSE down 1.3% and 0.3%, while Japan's Nikkei rose 0.7%.

US equities dropped overnight, with the Nasdaq Composite down 0.6% and the S&P 500 shedding 0.4%. The Dow decreased 0.3%. US markets are closed Thursday for Thanksgiving.

In macroeconomic news, New Zealand's business confidence index came in at 64.9 in November, down from 65.7 in October but still at an "impressive high," according to a ANZ Research.

Elsewhere, seasonally adjusted filled jobs across all industries slipped 0.1% to 2.4 million in October, Stats NZ data showed.

In corporate news, Fisher & Paykel Healthcare (NZE:FPH, ASX:FPH) lost nearly 2% after it reported earnings of NZ$0.26 per share for the first half of fiscal 2025, up from NZ$0.184 per share a year earlier but below the Visible Alpha consensus estimate of NZ$0.30.

Tower (NZE:TWR, ASX:TWR) rose past 2% after it logged a total profit after tax of NZ$74.3 million, compared with a loss of NZ$1 million in the year-earlier period. Analysts polled by Visible Alpha expected NZ$75.5 million.

Ryman Healthcare (NZE:RYM) lost over 6% in the wake of its half-year results, with earnings of NZ$0.136 per share, down from NZ$0.272 per share a year earlier and below Visible Alpha's expected EPS of NZ$0.204.